Significantly higher and more rapid cytogenetic and molecular responses can be achieved in pre-treated chronic phase CML patients with high doses of Imatinib as induction therapy (800 mg/day, 6 months) - final results of a Phase III CELSG CML11 "ISTAHIT"

Petzer, Andreas L; ...; Bogdanovic, Andrija D; ...; (broj, koautora 20)

Results

eNauka > Results > Significantly higher and more rapid cytogenetic and molecular responses can be achieved in pre-treated chronic phase CML patients with high doses of Imatinib as induction therapy (800 mg/day, 6 months) - final results of a Phase III CELSG CML11 "ISTAHIT"

Title:	Significantly higher and more rapid cytogenetic and molecular responses can be achieved in pre-treated chronic phase CML patients with high doses of Imatinib as induction therapy (800 mg/day, 6 months) - final results of a Phase III CELSG CML11 "ISTAHIT"
Authors:	Petzer, Andreas L; ...; Bogdanovic, Andrija D ; ...; (broj, koautora 20)
Issue Date:	2010
Publication:	ONKOLOGIE
ISSN:	0378-584X Onkologie Search Idenfier
Type:	Conference Paper
Collation:	vol. 33 str. 83-83
WoS-ID:	000282988400224
URI:	https://enauka.gov.rs/handle/123456789/800788
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM